Did your facility make the cut? For its 2023-2024 list, U.S. News and World Report evaluated data from 119 hospitals and surveyed thousands of pediatric specialists.

Artificial intelligence will be one of the hottest topics at the upcoming American Society of Echocardiography meeting in National Harbor, Maryland. 

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

The new-look DCB was designed to provide care with a significantly lower drug load than similar devices. 

Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.

Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

Coronary CT angiography is commonly used to assess patients at low or intermediate risk of CAD but is less effective in high-risk patients with an increased presence of coronary calcifications and stents due to the “blooming” effect they have on imaging.

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.